PDCD4 and pancreatic ductal adenocarcinoma: Only one previous study has evaluated PDCD4 immunohistochemical expression patterns, nuclear vs. cytoplasmic, in pancreatic ductal adenocarcinoma prognosis, but this study was based on a small patient cohort, and PDCD4 subcellular expression levels were measured using semiquantitative methods [37,38].